Discovery of FK‐506 and Update
- 1 June 1993
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 685 (1) , 13-21
- https://doi.org/10.1111/j.1749-6632.1993.tb35846.x
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- The mechanism of action of cyclosporin A and FK506Published by Elsevier ,2003
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Chemistry of tricarbonyl hemiketals and application of Evans technology to the total synthesis of the immunosuppressant (-)-FK-506Journal of the American Chemical Society, 1990
- FK506 AS THE SOLE IMMUNOSUPPRESSIVE AGENT FOR PROLONGATION OF ISLET ALLOGRAFT SURVIVAL IN THE RATTransplantation, 1990
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosusClinical Immunology and Immunopathology, 1989
- Immunosuppressive effect of FK506 on collagen-induced arthritis in ratsClinical Immunology and Immunopathology, 1988
- Immunosuppressive effect of FK506 on experimental allergic encephalomyelitis in ratsInternational Journal of Immunopharmacology, 1988
- Liver Transplantation with Use of Cyclosporin a and PrednisoneNew England Journal of Medicine, 1981
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981